Know Cancer

or
forgot password
  • cancer clinical trials in tennessee

  • Study of MLN8237 in Patients With Advanced Hematological Malignancies
    Sarah Cannon Research Institute
    Nashville, Tennessee 37203
    B-cell Follicular Lymphoma, B-cell Marginal Zone Lymphoma, Diffuse Large B-cell Lymphoma, B-cell Mantle Cell Lymphoma, B-cell Small Lymphocytic Lymphoma (SLL), B-Cell Chronic Lymphocytic Leukemia (B-CLL), Multiple Myeloma, Waldenstrom's Macroglobulinemia, Noncutaneous Peripheral T-cell Lymphoma Not Otherwise Specified (PTCL-NOS), Angioimmunoblastic T-cell Lymphoma (AITL), Anaplastic Large Cell Lymphoma, Enteropathy Associated T-cell Lymphoma (EATCL), NK Lymphoma (NKL)
    Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic Malignancies
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Juvenile Myelomonocytic Leukemia, Myelodysplastic Syndrome, Non-Hodgkin's Lymphoma
    International Pediatric Adrenocortical Tumor Registry
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Adrenocortical Tumor
    Phase III Study of Docetaxel + Ramucirumab or Placebo in Breast Cancer
    ImClone Investigational Site
    Memphis, Tennessee 38104
    Breast Cancer
    Bortezomib and Vorinostat in Treating Patients With Recurrent Mantle Cell Lymphoma or Recurrent and/or Refractory Diffuse Large B-Cell Lymphoma
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Mantle Cell Lymphoma
    Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer
    Vanderbilt University Medical Center
    Nashville, Tennessee 37232-2516
    Thyroid Cancer
    Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer
    Chattanooga Oncology and Hematology Associates

    Trial Locations
    Chattanooga Oncology and Hematology Associates
    Sarah Cannon Research Institute
    Non Small Cell Lung Cancer
    Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study
    Sarah Cannon Research Institute
    Nashville, Tennessee 37203
    Secondary Acute Myeloid Leukemia (Secondary AML, sAML)
    Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy
    East Tennessee Children's Hospital
    Knoxville, Tennessee 37901
    Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Liver Cancer, Neuroblastoma, Ototoxicity, Ovarian Cancer, Sarcoma
    Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)
    Chattanooga Oncology and Hematology Assoicates, PC Memorial Plaza

    Trial Locations
    Chattanooga Oncology and Hematology Assoicates, PC Memorial Plaza
    Tennessee Oncology Dept. of Centennial Medical
    Myelogenous Leukemia, Chronic
    Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    East Tennessee Childrens Hospital
    Knoxville, Tennessee 37916
    Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Pazopanib Versus Sunitinib in the Treatment of Locally Advanced and/or Metastatic Renal Cell Carcinoma
    GSK Investigational Site
    Germantown, Tennessee 38138
    Carcinoma, Renal Cell
    A Phase I Dose-Escalation Study of IMGN388 in Patients With Solid Tumors
    Sarah Cannon Research Institute
    Nashville, Tennessee 37203
    Solid Tumor
    Evaluation of a New Anti-cancer Immunotherapy After Chemotherapy in Adult Patients With Acute Myeloid Leukemia
    GSK Investigational Site
    Germantown, Tennessee 38138
    WT1-positive Acute Myeloid Leukemia, Leukaemia, Myelocytic, Acute
    BIBW 2992 (Afatinib) With or Without Daily Temozolomide in the Treatment of Patients With Recurrent Malignant Glioma
    1200.36.0020 Boehringer Ingelheim Investigational Site
    Memphis, Tennessee
    Glioma
    A Study for Safety and Effectiveness of IMC-A12 by Itself or Combined With Antiestrogens to Treat Breast Cancer
    ImClone Investigational Site
    Memphis, Tennessee 38104
    Metastatic Breast Cancer
    A Phase 1b Study of MDX-1106 in Subjects With Advanced or Recurrent Malignancies
    Sarah Cannon Research Institute

    Trial Locations
    Sarah Cannon Research Institute
    Vanderbilt-Ingram Cancer Ctr
    Metastatic Castration-resistant Prostrate Cancer (mCRPC), Renal Cell Carcinoma (RCC), Metastatic Melanoma (MEL), Non-small Cell Lung Cancer (NSCLC)
    Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Renal Cell Carcinoma
    FTY720 in Patients With Primary Progressive Multiple Sclerosis
    Sibyl Wray Neurology, PC

    Trial Locations
    Sibyl Wray Neurology, PC
    Vanderbilt University
    Primary Progressive Multiple Sclerosis
    Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
    T C Thompson Children's Hospital

    Trial Locations
    T C Thompson Children's Hospital
    East Tennessee Childrens Hospital
    St. Jude Children's Research Hospital
    Vanderbilt-Ingram Cancer Center
    Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Angioimmunoblastic T-cell Lymphoma, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Grade III Lymphomatoid Granulomatosis, Childhood Immunoblastic Large Cell Lymphoma, Childhood Myelodysplastic Syndromes, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma, Essential Thrombocythemia, Extramedullary Plasmacytoma, Intraocular Lymphoma, Isolated Plasmacytoma of Bone, Juvenile Myelomonocytic Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Mast Cell Leukemia, Meningeal Chronic Myelogenous Leukemia, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Polycythemia Vera, Post-transplant Lymphoproliferative Disorder, Primary Central Nervous System Hodgkin Lymphoma, Primary Central Nervous System Non-Hodgkin Lymphoma, Primary Myelofibrosis, Primary Systemic Amyloidosis, Progressive Hairy Cell Leukemia, Initial Treatment, Prolymphocytic Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Stage 0 Chronic Lymphocytic Leukemia, Stage I Childhood Anaplastic Large Cell Lymphoma, Stage I Childhood Hodgkin Lymphoma, Stage I Childhood Large Cell Lymphoma, Stage I Childhood Lymphoblastic Lymphoma, Stage I Childhood Small Noncleaved Cell Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Multiple Myeloma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage II Childhood Anaplastic Large Cell Lymphoma, Stage II Childhood Hodgkin Lymphoma, Stage II Childhood Large Cell Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage II Childhood Small Noncleaved Cell Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Multiple Myeloma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Childhood Anaplastic Large Cell Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage III Childhood Small Noncleaved Cell Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Multiple Myeloma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage IV Childhood Anaplastic Large Cell Lymphoma, Stage IV Childhood Hodgkin Lymphoma, Stage IV Childhood Large Cell Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, Stage IV Childhood Small Noncleaved Cell Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, T-cell Large Granular Lymphocyte Leukemia, Unspecified Childhood Solid Tumor, Protocol Specific, Untreated Childhood Acute Lymphoblastic Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies, Untreated Hairy Cell Leukemia, Waldenström Macroglobulinemia
    MLN8237 in Young Patients With Relapsed or Refractory Solid Tumors or Acute Lymphoblastic Leukemia
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Leukemia, Neuroblastoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors
    Sarah Cannon Research Institute
    Nashville, Tennessee 37203
    Non-Small Cell Lung Cancer, Prostate Cancer, Pancreatic Cancer
    A Phase I Trial Of The Humanized Anti-GD2 Antibody In Children And Adolescents With Neuroblastoma, Osteosarcoma Or Melanoma
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Neuroblastoma, Melanoma, Osteosarcoma
    Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer
    University of Tennessee Cancer Institute
    Memphis, Tennessee 38103
    Prostatic Neoplasms
    Head & Neck Cancer Survivorship: Physical and Functional Status
    Vanderbilt-Ingram Cancer Center

    Trial Locations
    Vanderbilt-Ingram Cancer Center
    Vanderbilt-Ingram Cancer Center - Cool Springs
    Vanderbilt-Ingram Cancer Center at Franklin
    Head and Neck Cancer
    Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder
    Vanderbilt-Ingram Cancer Center - Cool Springs

    Trial Locations
    Vanderbilt-Ingram Cancer Center - Cool Springs
    Vanderbilt-Ingram Cancer Center at Franklin
    Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    PK Trial of Sorafenib & Erlotinib in Patients With Refractory Solid Tumors
    Tennessee Oncology
    Nashville, Tennessee 37203
    Refractory Solid Tumors
    Establishment of a Lifetime of Cohort of Adults Surviving Childhood Cancer
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Cancer
    A Study of Pemetrexed, Carboplatin and Bevacizumab in Patients With Nonsquamous Non-Small Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Memphis, Tennessee 38138
    Non-small Cell Lung Cancer
    Lenalidomide With or Without Rituximab After Standard Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma
    Vanderbilt-Ingram Cancer Center

    Trial Locations
    Vanderbilt-Ingram Cancer Center
    Vanderbilt-Ingram Cancer Center - Cool Springs
    Vanderbilt-Ingram Cancer Center at Franklin
    Lymphoma
    S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery
    Christine LaGuardia Phillips Cancer Center at Wellmont Holston Valley Medical Center

    Trial Locations
    Christine LaGuardia Phillips Cancer Center at Wellmont Holston Valley Medical Center
    U.T. Medical Center Cancer Institute
    Malignant Mesothelioma
    Clinical Study of the Sonablate® 500 to Treat Localized (T1c/T2a) Prostate Cancer
    HIFU Site: Urology Associates
    Nashville, Tennessee 37209
    Prostate Cancer
    Neuropsychological and Behavioral Testing in Young Patients With Cancer
    East Tennessee Childrens Hospital

    Trial Locations
    East Tennessee Childrens Hospital
    St. Jude Children's Research Hospital
    Vanderbilt-Ingram Cancer Center
    Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity, Unspecified Childhood Solid Tumor, Protocol Specific
    Preoperative Chemotherapy in Triple Negative Invasive Breast Cancer That Can be Removed by Surgery.
    University of Tennessee Cancer Institute

    Trial Locations
    University of Tennessee Cancer Institute
    The West Clinic
    Breast Cancer